Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.056 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.9 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |